Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapaconazole vs Ketoconazole in Tinea Pedis
NCT02606383Phase 3Withdrawn
- Sponsor
- Biolab Farmacêutica
- Start
- Jun 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapaconazole in tinea pedis, sponsored by Biolab Farmacêutica. Planned start Jun 2016; status: withdrawn.
02
Drugs
dapaconazole
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT02606383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02606383.